Nomura Holdings’s PTC Therapeutics PTCT Stock Holding History

Nomura Holdings’s Portfolio PTCT Stock Details PTCT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-16,150	Closed	-$765K	–	2271
2021 Q1	$765K	Buy	16,150 +5,150	+47%	+$306K	﹤0.01%	1194
2020 Q4	$674K	Hold	11,000	–	–	﹤0.01%	1160
2020 Q3	$513K	Buy	+11,000	New	+$542K	﹤0.01%	999
2020 Q2	–	Sell	-45,000	Closed	-$2M	–	1243
2020 Q1	$2M	Buy	+45,000	New	+$2.27M	0.01%	464
2019 Q4	–	Sell	-6,550	Closed	-$212K	–	1296
2019 Q3	$212K	Buy	+6,550	New	+$285K	﹤0.01%	1081
2019 Q2	–	Sell	-23,985	Closed	-$912K	–	1282
2019 Q1	$912K	Sell	23,985 -6,064	-20%	-$204K	﹤0.01%	830
2018 Q4	$1.03M	Buy	30,049 +2,262	+8%	+$81.3K	﹤0.01%	858
2018 Q3	$1.29M	Buy	27,787 +4,757	+21%	+$197K	﹤0.01%	856
2018 Q2	$777K	Buy	+23,030	New	+$718K	﹤0.01%	917
2017 Q3	–	Sell	-50,672	Closed	-$928K	–	1585
2017 Q2	$928K	Buy	50,672 +11,300	+29%	+$152K	﹤0.01%	1065
2017 Q1	$384K	Buy	+39,372	New	+$477K	﹤0.01%	998
2013 Q4	–	Sell	-12,379	Closed	-$262K	–	2247
2013 Q3	$262K	Buy	+12,379	New	+$215K	﹤0.01%	1750

Other funds holding PTCT

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Nomura Holdings's PTCT Position: Q2 2021 in Review

Nomura Holdings sold out of PTC Therapeutics (PTCT) in Q2 2021, closing a stake of 16,150 shares — an estimated $765K sold.

Nomura Holdings first reported a position in PTCT in Q3 2013 and held it in 12 quarters. The position peaked at $2M in Q1 2020. 182 funds tracked by Wall St. Rank hold PTCT as of Q2 2021.

Nomura Holdings reported no remaining PTC Therapeutics position as of Q2 2021 after selling out during the quarter.
Nomura Holdings sold 16,150 PTC Therapeutics shares in Q2 2021, an estimated $765K.
Nomura Holdings first reported a position in PTC Therapeutics in Q3 2013 and held it in 12 quarters.
Nomura Holdings's PTC Therapeutics position peaked at $2M in Q1 2020.
182 funds tracked by Wall St. Rank held PTC Therapeutics as of Q2 2021.

Based on Nomura Holdings's 13F filing for Q2 2021, filed 16 Aug 2021.